Sinopharm Group Co Ltd (SHTDF) Stock Price & News

Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted. Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia

About Sinopharm Group Co Ltd

CEO-

Employees90.4K

Founded2003

Headquarters-

SectorHealth care provider

Websitesinopharm.com

All values in CNY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	145.44B	143.69B	140.77B	142.03B
Cost of goods sold	134.52B	133.28B	131.40B	132.33B
Cost of revenue	134.52B	133.28B	131.40B	132.33B
Research and development expenses	172.61M	-172.61M	46.59M	-46.59M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.17B	7.34B	5.10B	5.70B
Operating expense	6.80B	5.00B	6.29B	5.43B
Total operating expenses	141.32B	138.29B	137.69B	137.76B
Operating income	4.12B	5.40B	3.07B	4.28B
Other non operating income	120.78M	-427.44M	39.60M	-118.14M
EBT including unusual items	3.67B	3.92B	2.90B	4.05B
EBT excluding unusual items	3.51B	5.36B	2.90B	4.25B
Income tax expense	905.42M	1.19B	712.28M	1.05B
Effective tax rate	24.66%	30.30%	24.57%	26.02%
Other operating expenses	917.07M	-1.10B	204.49M	-392.73M
Net income	1.84B	1.85B	1.41B	1.99B
Net profit margin	1.27%	1.29%	1.00%	1.40%
Earnings per share	-	-	-	-
Interest and investment income	364.24M	-	171.27M	-
Interest expense	-412.56M	-846.59M	-383.82M	-505.78M
Net interest expenses	-48.32M	-846.59M	-212.55M	-505.78M
Depreciation and amortization charges	-	-	-	-
EBITDA	4.66B	5.91B	3.58B	4.78B
Gain or loss from assets sale	11.79M	-20.53M	-	-

Finance

Ask anything